-
Jul 26, 2024
Prospective competitors to newly popular anti-obesity and anti-diabetes drugs are heading toward commercialization.
-
May 3, 2024
Novo Nordisk, the maker of Ozempic and Wegovy, continues to enjoy booming sales, but supply constraints and pricing concerns are putting pressure on the stock.
-
Jan 5, 2024
Eli Lilly is poised to sell medicine directly to consumers — with an emphasis on newly popular weight-loss drugs — in a move toward cutting out the...
Jul 26, 2024Prospective competitors to newly popular anti-obesity and anti-diabetes drugs are heading toward commercialization.
May 3, 2024Novo Nordisk, the maker of Ozempic and Wegovy, continues to enjoy booming sales, but supply constraints and pricing concerns are putting pressure on the stock.
Jan 5, 2024Eli Lilly is poised to sell medicine directly to consumers — with an emphasis on newly popular weight-loss drugs — in a move toward cutting out the...